|
1
|
Mitterberger MJ, Aigner F, Horninger W, et
al: Comparative efficiency of contrast-enhanced colour Doppler
ultrasound targeted versus systematic biopsy for prostate cancer
detection. Eur Radiol. 20:2791–2796. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ploussard G, Nicolaiew N, Marchand C, et
al: Risk of repeat biopsy and prostate cancer detection after an
initial extended negative biopsy: longitudinal follow-up from a
prospective trial. BJU Int. 111:988–996. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Nelson ED, Slotoroff CB, Gomella LG and
Halpern EJ: Targeted biopsy of the prostate: the impact of color
Doppler imaging and elastography on prostate cancer detection and
Gleason score. Urology. 70:1136–1140. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen MK, Luo Y, Zhang H, et al:
Investigation of optimal prostate biopsy schemes for Chinese
patients with different clinical characteristics. Urol Int.
89:425–432. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kamoi K, Okihara K, Ochiai A, et al: The
utility of transrectal real-time elastography in the diagnosis of
prostate cancer. Ultrasound Med Biol. 34:1025–1032. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Puech P, Huglo D, Petyt G, Lemaitre L and
Villers A: Imaging of organ-confined prostate cancer: functional
ultrasound, MRI and PET/computed tomography. Curr Opin Urol.
19:168–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Miao H, Fukatsu H and Ishigaki T: Prostate
cancer detection with 3-T MRI: comparison of diffusion-weighted and
T2-weighted imaging. Eur J Radiol. 61:297–302. 2007. View Article : Google Scholar
|
|
8
|
Osugi K, Tanimoto A, Nakashima J, et al:
What is the most effective tool for detecting prostate cancer using
a standard MR scanner? Magn Reson Med Sci. 12:271–280. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
D’Amico AV, Tempany CM, Cormack R, et al:
Transperineal magnetic resonance image guided prostate biopsy. J
Urol. 164:385–387. 2000. View Article : Google Scholar
|
|
10
|
Park BK, Lee HM, Kim CK, Choi HY and Park
JW: Lesion localization in patients with a previous negative
transrectal ultrasound biopsy and persistently elevated prostate
specific antigen level using diffusion-weighted imaging at three
Tesla before rebiopsy. Invest Radiol. 43:789–793. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hambrock T, Somford DM, Hoeks C, et al:
Magnetic resonance imaging guided prostate biopsy in men with
repeat negative biopsies and increased prostate specific antigen. J
Urol. 183:520–527. 2010. View Article : Google Scholar
|
|
12
|
Singh AK, Krieger A, Lattouf JB, et al:
Patient selection determines the prostate cancer yield of dynamic
contrast-enhanced magnetic resonance imaging-guided transrectal
biopsies in a closed 3-Tesla scanner. BJU Int. 101:181–185.
2008.
|
|
13
|
Wang R, Chen JJ, Zhou YC, et al:
Evaluation of diffusion-weighted magnetic resonance imaging and
contrast-enhanced harmonic ultrasonography in detection and
location of prostate transition-zone cancer. J Int Med Res.
39:256–266. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Eri LM, Thomassen H, Brennhovd B and
Håheim LL: Accuracy and repeatability of prostate volume
measurement by transrectal ultrasound. Prostate Cancer Prostatic
Dis. 5:273–278. 2002. View Article : Google Scholar
|
|
15
|
Abdollah F, Scattoni V, Raber M, et al:
The role of transrectal saturation biopsy in tumour localization:
pathological correlation after retropubic radical prostatectomy and
implication for focal ablative therapy. BJU Int. 108:366–371. 2011.
View Article : Google Scholar
|
|
16
|
Salomon G, Drews N, Autier P, et al:
Incremental detection rate of prostate cancer by real-time
elastography targeted biopsies in combination with a conventional
10-core biopsy in 1,024 consecutive patients. BJU Int. 113:548–553.
2014. View Article : Google Scholar
|
|
17
|
Jones JS, Patel A, Schoenfield L, et al:
Saturation technique does not improve cancer detection as an
initial prostate biopsy strategy. J Urol. 175:485–488. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rouvière O, Hartman RP and Lyonnet D:
Prostate MR imaging at high-field strength: evolution or
revolution? Eur Radiol. 16:276–284. 2006. View Article : Google Scholar
|
|
19
|
Busby JE and Evans CP: Determining
variables for repeat prostate biopsy. Prostate Cancer Prostatic
Dis. 7:93–98. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SJ, Miyake H, Hara I and Eto H:
Predictors of prostate cancer on repeat transrectal
ultrasound-guided systematic prostate biopsy. Int J Urol. 10:68–71.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chun FK, de la Taille A, van Poppel H, et
al: Prostate cancer gene 3 (PCA3): development and internal
validation of a novel biopsy nomogram. Eur Urol. 56:659–667. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cheikh AB, Girouin N, Colombel M, et al:
Evaluation of T2-weighted and dynamic contrast-enhanced MRI in
localizing prostate cancer before repeat biopsy. Eur Radiol.
19:770–778. 2009. View Article : Google Scholar
|
|
23
|
Prando A, Kurhanewicz J, Borges AP,
Oliveira EM Jr and Figueiredo E: Prostatic biopsy directed with
endorectal MR spectroscopic imaging findings in patients with
elevated prostate specific antigen levels and prior negative biopsy
findings: early experience. Radiology. 236:903–910. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Eskicorapci SY, Guliyev F, Islamoglu E,
Ergen A and Ozen H: The effect of prior biopsy scheme on prostate
cancer detection for repeat biopsy population: results of the
14-core prostate biopsy technique. Int Urol Nephrol. 39:189–195.
2007. View Article : Google Scholar
|
|
25
|
Scattoni V, Maccagnano C, Zanni G, et al:
Is extended and saturation biopsy necessary? Int J Urol.
17:432–447. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lattouf JB, Grubb RL 3rd, Lee SJ, et al:
Magnetic resonance imaging-directed transrectal
ultrasonography-guided biopsies in patients at risk of prostate
cancer. BJU Int. 99:1041–1046. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Shigemura K, Motoyama S and Yamashita M:
Do additional cores from MRI cancer-suspicious lesions to
systematic 12-core transrectal prostate biopsy give better cancer
detection? Urol Int. 88:145–149. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Ceylan C, Doluoglu OG, Aglamis E and
Baytok O: Comparison of 8, 10, 12, 16, 20 cores prostate biopsies
in the determination of prostate cancer and the importance of
prostate volume. Can Urol Assoc J. 8:E81–E85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Djavan B, Zlotta A, Remzi M, et al:
Optimal predictors of prostate cancer on report prostate biopsy: a
prospective study of 1,051 men. L Urol. 163:1144–1148. 2000.
View Article : Google Scholar
|
|
30
|
Ankerst DP, Till C, Boeck A, et al:
Predicting risk of prostate cancer in men receiving finasteride:
effect of prostate volume, number of biopsy cores, and American
Urological Association symptom score. Urology. 82:1076–1081. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Elshafei A, Li YH, Hatem A, et al: The
utility of PSA velocity in prediction of prostate cancer and high
grade cancer after an initially negative prostatebiopsy. Prostate.
73:1796–1802. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Kuligowaka E, Barish MA, Fenlon HM and
Blake M: Predictors of prostate carcinoma: accuracy of gray-scale
and color Doppler US and serum markers. Radiology. 220:757–764.
2001. View Article : Google Scholar
|
|
33
|
Ukimura O, Hirahara N, Fujihara A, et al:
Technique for a hybrid system of real-time transrectal ultrasound
with preoperative magnetic resonance imaging in the guidance of
targeted prostate biopsy. Int J Urol. 17:890–893. 2010. View Article : Google Scholar : PubMed/NCBI
|
